 |
|
Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality
Srjdan Prodanovich, MD;
Robert S. Kirsner, MD, PhD;
Jeffrey D. Kravetz, MD;
Fangchao Ma, MD, PhD;
Lisa Martinez, MD;
Daniel G. Federman, MD
Arch Dermatol. 2009;145(6):700-703.
Objective To examine the cardiovascular risk factors in patients with psoriasis and the association between psoriasis and coronary artery, cerebrovascular, and peripheral vascular diseases.
Design Observational study.
Setting Large Department of Veterans Affairs hospital.
Patients The study included 3236 patients with psoriasis and 2500 patients without psoriasis (controls).
Main Outcome Measures Using International Classification of Diseases, Ninth Revision, Clinical Modification, codes, we compared the prevalence of traditional cardiovascular risk factors and other vascular diseases as well as mortality between patients with psoriasis and controls.
Results Similar to previous studies, we found a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and smoking in patients with psoriasis. After controlling for these variables, we found a higher prevalence not only of ischemic heart disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.51-2.11) but also of cerebrovascular (OR, 1.70; 95% CI, 1.33-2.17) and peripheral vascular (OR, 1.98; 95% CI, 1.32-2.82) diseases in patients with psoriasis compared with controls. Psoriasis was also found to be an independent risk factor for mortality (OR, 1.86; 95% CI, 1.56-2.21).
Conclusions Psoriasis is associated with atherosclerosis. This association applies to coronary artery, cerebrovascular, and peripheral vascular diseases and results in increased mortality.
Author Affiliations: Departments of Dermatology and Cutaneous Surgery (Drs Prodanovich, Kirsner, and Martinez) and Epidemiology and Public Health (Dr Kirsner), University of Miami Miller School of Medicine, and Department of Dermatology, Miami Veterans Affairs Medical Center (Dr Kirsner), Miami, Florida; Departments of Medicine, Veterans Affairs Connecticut Health Care, West Haven (Drs Kravetz and Federman), and Yale University School of Medicine, New Haven (Drs Kravetz and Federman), Connecticut; and Epidemiologic Studies, Illinois Department of Public Health, Springfield, Illinois (Dr Ma).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Dermatology
Arch Dermatol. 2009;145(6):631.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Epidemiology and Potential Pathomechanisms of Cardiovascular Comorbidities in Psoriasis: A Report from the GRAPPA 2010 Annual Meeting
BOEHNCKE
The Journal of Rheumatology 2012;39:441-444.
ABSTRACT
| FULL TEXT
A 41 year old man with an itchy rash
Salgo and Boehncke
BMJ 2011;343:d7320-d7320.
FULL TEXT
Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT): A Pilot Study
Mehta et al.
Arch Dermatol 2011;147:1031-1039.
ABSTRACT
| FULL TEXT
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
Ahlehoff et al.
Eur Heart J 2011;0:ehr285v2-ehr285.
ABSTRACT
| FULL TEXT
High Prevalence of Subclinical Left Ventricular Dysfunction in Patients with Psoriatic Arthritis
SHANG et al.
The Journal of Rheumatology 2011;38:1363-1370.
ABSTRACT
| FULL TEXT
Statistics: Producing Unreliable Facts from Reliable Figures?
Journal Watch Dermatology 2010;2010:2-2.
FULL TEXT
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
Mehta et al.
Eur Heart J 2010;31:1000-1006.
ABSTRACT
| FULL TEXT
|
